Researchers: More patient education may improve drug compliance

04/23/2013 | Medscape (free registration)

More patient education about cholinesterase inhibitor drugs may help Alzheimer's disease patients with lower education levels stick with their medication regimens, University of Saskatchewan researchers reported at the Alzheimer's Disease International 28th International Conference. The study found people with less formal education were more likely to stop taking the drugs, suggesting that if clinicians spend more time explaining what to expect from the medication it could improve compliance.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD